NCI NeoConcept CEO outlines global market expansion priorities following the release of its latest quarterly earnings Pfizer Inc PFE Strategic CDK Inhibitor Supply Partnership with Relay Therapeutics Validates Atirmociclib Commercial Potential in Metastatic Breast Cancer ACR ACRES management lays out key new strategic priorities to grow its commercial realty footprint this year NC NACCO Industries shares gain 45 percent after posting a Q4 2025 loss of 52 cents per share Estrella Immunopharma ESLA Stock Changing Trend Institutional Selling 20260427